NasdaqGS:BRKRLife Sciences
Bruker (BRKR) Q3 Loss Of US$62 Million Tests Bullish Margin Narratives
Bruker (BRKR) just posted its FY 2025 third quarter numbers with revenue of US$860.5 million and a basic EPS loss of US$0.41, while trailing twelve month revenue sits at about US$3.4 billion with a small net loss. The company has seen quarterly revenue move from US$800.7 million in Q2 2024 to US$979.6 million in Q4 2024, then track around the low US$800 million range through the first three quarters of 2025, as EPS shifted from a modest profit in early 2025 into a Q3 loss. With margins...